The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers
Open accessThe DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribosyl)ation (PARylation) is catalysed by poly(ADP-ribose) polymerases (PARPs, also known as ARTDs) and then rapidly removed by degrading enzymes. Poly(ADP-ribose) (PAR) is produced from PARylation and provides a delicate and spatiotemporal interaction scaffold for numerous target proteins. The PARylation system, consisting of PAR synthesizers and erasers and PAR itself and readers, plays diverse roles in the DNA damage response (DDR), DNA repair, transcription, replication, chromatin remodeling, metabolism, and cell death. Despite great efforts by scientists in biochemistry, cell and molecular biology, genetics, and pharmacology over the last five decades, the biology of PARPs and PARylation remains enigmatic. In this review, we summarize the current understanding of the biological function of PARP1 (ARTD1), the founding member of the PARP family, focusing on the inter-dependent or -independent nature of different functional domains of the PARP1 protein. We also discuss the readers of PAR, whose function may transduce signals and coordinate the cellular processes, which has recently emerged as a new research avenue for PARP biology. We aim to provide some perspective on how future research might disentangle the biology of PARylation by dissecting the structural and functional relationship of PARP1, a major effector of the PARPs family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Ray Chaudhuri, A., & Nussenzweig, A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.53 · Cited by 1,786 · cited 2×
“In general, PARP1 is located in the nucleus and is activated after binding to SSBs and also DSBs, to catalyze PARylation of itself (automodification) and of various acceptor proteins (heteromodification) [10].”
BackgroundRole of poly(ADP-ribose) formation in DNA repair
Satoh, M. S., & Lindahl, T. (1992) · Nature · doi:10.1038/356356a0 · Cited by 1,174 · cited 2×
“Where PARP1 is not present, the major BER is not affected—or likely some other mechanism can substitute PARP1 [38,39].”
BackgroundRequirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells
de Murcia, J. M., Niedergang, C., Trucco, C., Ricoul, M., Dutrillaux, B., Mark, M., Oliver, F. J., Masson, M., Dierich, A., LeMeur, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7303 · Cited by 1,056 · cited 2×
“The deletion of the entire PARP1 protein however cannot simply refer to the functions of PARP1—the most fascinating of which is that the lack of PARP1 in cells and mouse models leads to both negative (cytotoxic and genotoxic stress) and positive outcomes (protective inflammatory response) [40,44,45].”
BackgroundPoly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia
Eliasson, M. J. L., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J., Pieper, A., Wang, Z.-Q., Dawson, T. M., Snyder, S. H., et al. (1997) · Nature Medicine · doi:10.1038/nm1097-1089 · Cited by 1,018
Self-citationMurzin, A. G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05726.x · Cited by 920 · cited 1×
“OB-fold Antiparallel β-barrel β1-β2-β3-β5-β4-β1 [84]”
Role of Poly(ADP-ribose) Polymerase (PARP) Cleavage in Apoptosis
Boulares, A. H., Yakovlev, A. G., Ivanova, V., Stoica, B. A., Wang, G., Iyer, S., & Smulson, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.22932 · Cited by 899
PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R. H., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.004 · Cited by 837 · cited 1×
“, found that PARP1−/− mice have enhanced energy consumption but weigh less [61].”
BackgroundThe PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
Krishnakumar, R., & Kraus, W. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.017 · Cited by 836
Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.
Wang, Z. Q., Auer, B., Stingl, L., Berghammer, H., Haidacher, D., Schweiger, M., & Wagner, E. F. (1995) · Genes & Development · doi:10.1101/gad.9.5.509 · Cited by 774 · cited 2×
“The authors showed that mouse embryonic fibroblasts (MEFs) derived from PARP1 null mice displayed negligible DNA repair defects [37].”
BackgroundSelf-citationImportance of Poly(ADP-ribose) Polymerase and Its Cleavage in Apoptosis
Oliver, F. J., de la Rubia, G., Rolli, V., Ruiz-Ruiz, M. C., de Murcia, G., & Murcia, J. M.-D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33533 · Cited by 754 · cited 2×
“Interestingly, PARP1−/−mice are sensitive to acute radiation-induced toxicity of the small intestine [40,41]; whilst other studies show that PARP1−/− cells have a hypersensitivity to cell death induced by alkylating agents [40,42].”
BackgroundOn PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
Luo, X., & Kraus, W. L. (2012) · Genes & Development · doi:10.1101/gad.183509.111 · Cited by 725 · cited 1×
“Among them, PARP1 is a founding member of this family, well-known for its essential function in DNA damage repair and other cellular processes, such as chromatin remodeling, transcription and cell death signaling [2,6,7].”
BackgroundPARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Gupte, R., Liu, Z., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.291518.116 · Cited by 681 · cited 7×
“PARP3 interacts with proteins involved in BER and NHEJ pathways, indicating its role in DNA repair.”
BackgroundInfluentialStructural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1
Langelier, M.-F., Planck, J. L., Roy, S., & Pascal, J. M. (2012) · Science · doi:10.1126/science.1216338 · Cited by 665 · cited 1×
“A nuclear localization sequence (NLS, sequence: KRK-X(11)–KKKSKK) is also located in the N-terminal region that leads PARP1 to the nucleus [16,17].”
BackgroundEl-Khamisy, S. F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg761 · Cited by 659 · cited 1×
“Mutations LI360/361DD, W385D, and C389A in BRCT compromise the accumulation of XRCC1 at damaged sites [90,91].”
BackgroundMenissier de Murcia, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg206 · Cited by 627 · cited 3×
“PARP2 knock-out mice develop normally but are hypersensitive to whole-body radiation [47].”
BackgroundIschemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase
Endres, M., Wang, Z.-Q., Namura, S., Waeber, C., & Moskowitz, M. A. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199711000-00002 · Cited by 622 · cited 1×
“Apart from being resistant to septic shock, PARP1 null mice show a certain degree of protection from other disease induction, such as ischemic stroke [55,56], traumatic brain injury [57], and streptozotocin-induced diabetes [58,59], indicating the role of PARP1 in the pathogenesis of these diseases.”
BackgroundSelf-citationRING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination
Metzger, M. B., Pruneda, J. N., Klevit, R. E., & Weissman, A. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.026 · Cited by 611 · cited 1×
“The binding occurs via PAR clamping between the WWE/PBM and RING domains, which changes the conformation of RING and activates Iduna E3 ligase activity [104,105].”
BackgroundPost-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks
Lindahl, T., Satoh, M. S., Poirier, G. G., & Klungland, A. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89089-1 · Cited by 611 · cited 1×
“Where PARP1 is not present, the major BER is not affected—or likely some other mechanism can substitute PARP1 [38,39].”
BackgroundLiquid demixing of intrinsically disordered proteins is seeded by poly(ADP-ribose)
Altmeyer, M., Neelsen, K. J., Teloni, F., Pozdnyakova, I., Pellegrino, S., Grøfte, M., Rask, M.-B. D., Streicher, W., Jungmichel, S., Nielsen, M. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms9088 · Cited by 587 · cited 1×
“RRM ASF/SF2, CIRBP, FUS/TLS, TAF15, EWS, NONO DNA damage, RNA processing [85,87,99,129,130]”
BackgroundOliver, F. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4446 · Cited by 582 · cited 1×
“The lack of PARP1 leads to a remarkable decrease in the release of inflammatory mediators downstream of NF-kB transcription factor [44,54].”
BackgroundPARP is important for genomic stability but dispensable in apoptosis
Wang, Z.-Q., Stingl, L., Morrison, C., Jantsch, M., Los, M., Schulze-Osthoff, K., & Wagner, E. F. (1997) · Genes & Development · doi:10.1101/gad.11.18.2347 · Cited by 557 · cited 3×
“A prominent phenotype of PARP knock-out mice and cells is a general decrease of genomic stability, characterized by an elevated rate of sister chromatid exchanges (SCEs) and an increased frequency of chromosome breaks, chromosome fusions, aneuploidy, and telomere shortening—demonstrating that this enzyme has a pivotal…”
BackgroundSelf-citationLos, M., Mozoluk, M., Ferrari, D., Stepczynska, A., Stroh, C., Renz, A., Herceg, Z., Wang, Z.-Q., & Schulze-Osthoff, K. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-05-0272 · Cited by 504
Self-citationPoly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
Alemasova, E. E., & Lavrik, O. I. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz120 · Cited by 497
Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death
Herceg, Z., & Wang, Z.-Q. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00111-7 · Cited by 488 · cited 1×
“PAR binders participate in the regulation of cell cycle progression, genome maintenance and transcription regulation [100,101].”
BackgroundSelf-citationWang, Y., Kim, N. S., Haince, J.-F., Kang, H. C., David, K. K., Andrabi, S. A., Poirier, G. G., Dawson, V. L., & Dawson, T. M. (2011) · Science Signaling · doi:10.1126/scisignal.2000902 · Cited by 476
RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling
Zhang, Y., Liu, S., Mickanin, C., Feng, Y., Charlat, O., Michaud, G. A., Schirle, M., Shi, X., Hild, M., Bauer, A., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2222 · Cited by 431 · cited 2×
“Iduna also binds Axin immediately after Axin PARylation by tankyrase, and ubiquitinates it, leading to activation of Wnt signaling [108,109].”
BackgroundPoly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins
Ahel, I., Ahel, D., Matsusaka, T., Clark, A. J., Pines, J., Boulton, S. J., & West, S. C. (2008) · Nature · doi:10.1038/nature06420 · Cited by 429
A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation
Timinszky, G., Till, S., Hassa, P. O., Hothorn, M., Kustatscher, G., Nijmeijer, B., Colombelli, J., Altmeyer, M., Stelzer, E. H. K., Scheffzek, K., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1664 · Cited by 416 · cited 3×
“1 influences chromatin rearrangement differently [103].”
BackgroundInfluentialGagné, J.-P., Isabelle, M., Lo, K. S., Bourassa, S., Hendzel, M. J., Dawson, V. L., Dawson, T. M., & Poirier, G. G. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn771 · Cited by 414
The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase
Slade, D., Dunstan, M. S., Barkauskaite, E., Weston, R., Lafite, P., Dixon, N., Ahel, M., Leys, D., & Ahel, I. (2011) · Nature · doi:10.1038/nature10404 · Cited by 381
Burkart, V., Wang, Z.-Q., Radons, J., Heller, B., Herceg, Z., Stingl, L., Wagner, E. F., & Kolb, H. (1999) · Nature Medicine · doi:10.1038/6535 · Cited by 372 · cited 1×
“Apart from being resistant to septic shock, PARP1 null mice show a certain degree of protection from other disease induction, such as ischemic stroke [55,56], traumatic brain injury [57], and streptozotocin-induced diabetes [58,59], indicating the role of PARP1 in the pathogenesis of these diseases.”
BackgroundSelf-citationSerine ADP-ribosylation depends on HPF1
Bonfiglio, J. J., Fontana, P., Zhang, Q., Colby, T., Gibbs-Seymour, I., Atanassov, I., Bartlett, E., Zaja, R., Ahel, I., & Matic, I. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.003 · Cited by 352
DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines
Trucco, C. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.11.2644 · Cited by 348 · cited 1×
“Moreover, PARP1-deficient cells accumulate in G2/M phase after treatment with methylmethanesulfonate (MMS) [43].”
BackgroundC2H2 zinc finger proteins greatly expand the human regulatory lexicon
Najafabadi, H. S., Mnaimneh, S., Schmitges, F. W., Garton, M., Lam, K. N., Yang, A., Albu, M., Weirauch, M. T., Radovani, E., Kim, P. M., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3128 · Cited by 346 · cited 1×
“PbR motif of Chk1 belongs to PBZ domains, but has the non-canonical structure [77,102].”
BackgroundAltmeyer, M., Messner, S., Hassa, P. O., Fey, M., & Hottiger, M. O. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp229 · Cited by 325 · cited 1×
“Furthermore, PARP1 lacking the WGR domain (aa 525–656) was shown to be incapable of producing PAR, whereas the deletion of the BRCT domain bore no influence on auto-modification as well as PAR formation [26].”
BackgroundFunction of BRCA1 in the DNA Damage Response Is Mediated by ADP-Ribosylation
Li, M., & Yu, X. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.025 · Cited by 321 · cited 1×
“BRCT BARD1, APLF, Ligase4, XRCC1, NBS1 DNA damage [74,118,127]”
Poly(ADP-ribose) polymerases in double-strand break repair: Focus on PARP1, PARP2 and PARP3
Beck, C., Robert, I., Reina-San-Martin, B., Schreiber, V., & Dantzer, F. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.07.003 · Cited by 302 · cited 4×
“It has also been shown to play pivotal roles in the repair of DNA double-strand breaks (DSBs) via homologous recombination (HR), as well as nonhomologous end joining (NHEJ) [9].”
BackgroundInfluentialThe Enzymatic and DNA Binding Activity of PARP-1 Are Not Required for NF-κB Coactivator Function
Hassa, P. O., Covic, M., Hasan, S., Imhof, R., & Hottiger, M. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106528200 · Cited by 296 · cited 1×
“Another interesting feature of PARP1-deficient mice is their attenuated response to endotoxic shock, diabetic induction, stroke, and intestinal and renal ischemia-reperfusion [44,52,53].”
BackgroundFunctions of PARylation in DNA Damage Repair Pathways
Wei, H., & Yu, X. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.05.001 · Cited by 296 · cited 1×
“The addition of the first ADPr moiety to the protein occurs covalently to the D, E, and K residues via an ester bond [66].”
BackgroundMasutani, M., Suzuki, H., Kamada, N., Watanabe, M., Ueda, O., Nozaki, T., Jishage, K.-I., Watanabe, T., Sugimoto, T., Nakagama, H., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2301 · Cited by 286 · cited 1×
“Apart from being resistant to septic shock, PARP1 null mice show a certain degree of protection from other disease induction, such as ischemic stroke [55,56], traumatic brain injury [57], and streptozotocin-induced diabetes [58,59], indicating the role of PARP1 in the pathogenesis of these diseases.”
BackgroundBoehler, C., Gauthier, L. R., Mortusewicz, O., Biard, D. S., Saliou, J.-M., Bresson, A., Sanglier-Cianferani, S., Smith, S., Schreiber, V., Boussin, F., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016574108 · Cited by 277
The zinc-finger domains of PARP1 cooperate to recognize DNA strand breaks
Ali, A. A. E., Timinszky, G., Arribas-Bosacoma, R., Kozlowski, M., Hassa, P. O., Hassler, M., Ladurner, A. G., Pearl, L. H., & Oliver, A. W. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2335 · Cited by 268 · cited 2×
“The substitution of V144 and P149 in ZFII (V144E/P149D and V144E/P149I) causes a similar defect in binding to a DNA lesion [25].”
BackgroundFunctions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability
Fagagna, F. D. D., Hande, M. P., Tong, W.-M., Lansdorp, P. M., Wang, Z.-Q., & Jackson, S. P. (1999) · Nature Genetics · doi:10.1038/12680 · Cited by 255 · cited 1×
“A prominent phenotype of PARP knock-out mice and cells is a general decrease of genomic stability, characterized by an elevated rate of sister chromatid exchanges (SCEs) and an increased frequency of chromosome breaks, chromosome fusions, aneuploidy, and telomere shortening—demonstrating that this enzyme has a pivotal…”
BackgroundSelf-citationIduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage
Kang, H. C., Lee, Y.-I., Shin, J.-H., Andrabi, S. A., Chi, Z., Gagné, J.-P., Lee, Y., Ko, H. S., Lee, B. D., Poirier, G. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108799108 · Cited by 254 · cited 2×
“One may assume that Iduna is able to clamp less branched and shortened PAR chains in the case of mild DNA damage, for example [110].”
BackgroundReaders of poly(ADP-ribose): designed to be fit for purpose
Teloni, F., & Altmeyer, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1383 · Cited by 247 · cited 2×
“The structures of these domains, their abundance and PAR patterns to interact with, have been well described [69].”
BackgroundWang, Z., Michaud, G. A., Cheng, Z., Zhang, Y., Hinds, T. R., Fan, E., Cong, F., & Xu, W. (2012) · Genes & Development · doi:10.1101/gad.182618.111 · Cited by 246 · cited 3×
“duplicated or triplicated binding domains that increase the stability of the complexes with PAR [74,75].”
BackgroundSelf-citationThe role of poly ADP-ribosylation in the first wave of DNA damage response
Liu, C., Vyas, A., Kassab, M. A., Singh, A. K., & Yu, X. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx565 · Cited by 240 · cited 1×
“, glutamates (E), lysine (K), arginine (R), serine (S), and aspartate (D)), on PARP1 itself and other acceptor proteins [1,2].”
BackgroundCrystal Structures of Poly(ADP-ribose) Polymerase-1 (PARP-1) Zinc Fingers Bound to DNA
Langelier, M.-F., Planck, J. L., Roy, S., & Pascal, J. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202507 · Cited by 239 · cited 5×
“F44A V48A F44A/V48A Lower auto-modification DNA-binding affinity, DNA-dependent PARP-1 activation [22]”
BackgroundInfluentialHerceg, Z., & Wang, Z.-Q. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5124 · Cited by 233
Self-citationAllosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal
DaRosa, P. A., Wang, Z., Jiang, X., Pruneda, J. N., Cong, F., Klevit, R. E., & Xu, W. (2015) · Nature · doi:10.1038/nature13826 · Cited by 229 · cited 2×
“The Kd of WWE–RING–PAR interaction is ten times higher (around 40 nM) than that of WWE–PAR (around 400 nM) [75,104].”
BackgroundSelf-citationNuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics
Hottiger, M. O. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034506 · Cited by 229 · cited 7×
“PARP3 interacts with proteins involved in BER and NHEJ pathways, indicating its role in DNA repair.”
BackgroundInfluentialMacrodomains: Structure, Function, Evolution, and Catalytic Activities
Rack, J. G. M., Perina, D., & Ahel, I. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014935 · Cited by 217 · cited 2×
“Macrodomain globular α/β/α sandwich β-α-β-α-α-β-β-α-β-α-β [79]”
Andrabi, S. A., Kang, H. C., Haince, J.-F., Lee, Y.-I., Zhang, J., Chi, Z., West, A. B., Koehler, R. C., Poirier, G. G., Dawson, T. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2387 · Cited by 216 · cited 1×
“Iduna ubiquitinates and degrades AIF, thereby preventing cell death [107].”
BackgroundARTD1/PARP1 Negatively Regulates Glycolysis by Inhibiting Hexokinase 1 Independent of NAD+ Depletion
Fouquerel, E., Goellner, E. M., Yu, Z., Gagné, J.-P., Barbi de Moura, M., Feinstein, T., Wheeler, D., Redpath, P., Li, J., Romero, G., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.036 · Cited by 212
Interactions between BRCT repeats and phosphoproteins: tangled up in two
Glover, J. N. M., Williams, R. S., & Lee, M. S. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.09.010 · Cited by 211
Langelier, M.-F., Servent, K. M., Rogers, E. E., & Pascal, J. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708558200 · Cited by 204 · cited 1×
“A nuclear localization sequence (NLS, sequence: KRK-X(11)–KKKSKK) is also located in the N-terminal region that leads PARP1 to the nucleus [16,17].”
BackgroundPARP family enzymes: regulation and catalysis of the poly(ADP-ribose) posttranslational modification
Langelier, M.-F., Eisemann, T., Riccio, A. A., & Pascal, J. M. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.11.002 · Cited by 196 · cited 1×
“For example, which of the described functions are related to the PARP1 protein itself and which are attributed to its enzymatic product PAR [2]? Several recent reviews have comprehensively described the PARP family [7,12,13] and also summarized development of PARP inhibitors in clinical applications [11,14,15].”
BackgroundPoly(ADP-ribose): An organizer of cellular architecture
Leung, A. K. L. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201402114 · Cited by 193
Rulten, S. L., Rotheray, A., Green, R. L., Grundy, G. J., Moore, D. A. Q., Gómez-Herreros, F., Hafezparast, M., & Caldecott, K. W. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt835 · Cited by 190 · cited 1×
“RRM ASF/SF2, CIRBP, FUS/TLS, TAF15, EWS, NONO DNA damage, RNA processing [85,87,99,129,130]”
BackgroundDNA repair: PARP – another guardian angel?
Jeggo, P. A. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70032-6 · Cited by 179
PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
Keung, M., Wu, Y., & Vadgama, J. V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040435 · Cited by 173
Role of Glutamic Acid 988 of Human Poly-ADP-ribose Polymerase in Polymer Formation
Marsischky, G. T., Wilson, B. A., & Collier, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3247 · Cited by 169 · cited 3×
“Mutation of this amino acid to glutamine (Q) and/or alanine (A) produces a more than 2000-fold reduction in the polymer elongation [30].”
BackgroundLangelier, M.-F., Ruhl, D. D., Planck, J. L., Kraus, W. L., & Pascal, J. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105668 · Cited by 167 · cited 2×
“ZFIII-deleted mutant is also enzymatically inactive because site-directed mutagenesis of the residues W318 and T316 in ZFIII abolishes DNA-dependent PARP1 activation [24].”
BackgroundThe FHA and BRCT domains recognize ADP-ribosylation during DNA damage response
Li, M., Lu, L.-Y., Yang, C.-Y., Wang, S., & Yu, X. (2013) · Genes & Development · doi:10.1101/gad.226357.113 · Cited by 164 · cited 2×
“BRCT BARD1, APLF, Ligase4, XRCC1, NBS1 DNA damage [74,118,127]”
BackgroundKrietsch, J., Caron, M.-C., Gagné, J.-P., Ethier, C., Vignard, J., Vincent, M., Rouleau, M., Hendzel, M. J., Poirier, G. G., & Masson, J.-Y. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks798 · Cited by 163 · cited 1×
“RRM ASF/SF2, CIRBP, FUS/TLS, TAF15, EWS, NONO DNA damage, RNA processing [85,87,99,129,130]”
BackgroundPoly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis
Tong, W.-M., Cortes, U., & Wang, Z.-Q. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00035-x · Cited by 163
Self-citationPARP2 mediates branched poly ADP-ribosylation in response to DNA damage
Chen, Q., Kassab, M. A., Dantzer, F., & Yu, X. (2018) · Nature Communications · doi:10.1038/s41467-018-05588-5 · Cited by 162 · cited 6×
“In addition, tandem PBZ motifs of APLF recognize branched PAR chain, while each PBZ motif can independently bind one or two ADPr residues [113].”
BackgroundInfluentialFahrer, J., Kranaster, R., Altmeyer, M., Marx, A., & Bürkle, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm944 · Cited by 161 · cited 2×
“XPA forms a complex with 55-mer PAR chain, but not with ADPr shorter than 16-mer [115].”
BackgroundIles, N., Rulten, S., El-Khamisy, S. F., & Caldecott, K. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02269-06 · Cited by 159 · cited 6×
“duplicated or triplicated binding domains that increase the stability of the complexes with PAR [74,75].”
BackgroundInfluentialJubin, T., Kadam, A. A., Jariwala, M., Bhatt, S., Sutariya, S., Gani, A. R., Gautam, S., & Begum, R. (2016) · Cell Proliferation · doi:10.1111/cpr.12268 · Cited by 159 · cited 1×
“For example, which of the described functions are related to the PARP1 protein itself and which are attributed to its enzymatic product PAR [2]? Several recent reviews have comprehensively described the PARP family [7,12,13] and also summarized development of PARP inhibitors in clinical applications [11,14,15].”
BackgroundEckei, L., Krieg, S., Bütepage, M., Lehmann, A., Groß, A., Lippok, B. E., Grimm, A. R., Kümmerer, B. M., Rossetti, G., Lüscher, B., et al. (2017) · Scientific Reports · doi:10.1038/srep41746 · Cited by 159 · cited 1×
“Macrodomain MacroH2A, PARG, TARG1, MacroD1, MacroD2, macroD3, ALC1, ARTD7, ARTD8, ARTD9, PARP9, PARP14, PARP15, GDAP2 DNA damage, redox defense, chromatin architecture, protein acetylation, viral infection [79,119,120]”
Structure and Function of the Phosphothreonine-Specific FHA Domain
Mahajan, A., Yuan, C., Lee, H., Chen, E. S.-W., Wu, P.-Y., & Tsai, M.-D. (2008) · Science Signaling · doi:10.1126/scisignal.151re12 · Cited by 153
Rolli, V., O'Farrell, M. K., Murcia, J. M., & de MURCIA, G. (1997) · Biochemistry · doi:10.1021/bi971055p · Cited by 148 · cited 5×
“One of the fundamental studies performed to understand the structure–function relationship of PARP1 and the key residues involved in catalytic activity, was conducted using a library of human PARP mutants expressed in Escherichia coli, in which the mutations were mostly located in the catalytic domain [32].”
BackgroundInfluentialRegulation of Wnt/β‐catenin signalling by tankyrase‐dependent poly(ADP‐ribosyl)ation and scaffolding
Mariotti, L., Pollock, K., & Guettler, S. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14038 · Cited by 144 · cited 1×
“Iduna also binds Axin immediately after Axin PARylation by tankyrase, and ubiquitinates it, leading to activation of Wnt signaling [108,109].”
BackgroundMin, W., Bruhn, C., Grigaravičius, P., Zhou, Z., Li, F., Krüger, A., Siddeek, B., Greulich, K., Popp, O., Meisezahl, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3993 · Cited by 142
Self-citationPoly-ADP-ribosylation in health and disease: Introduction to poly(ADP-ribose) metabolism
Diefenbach, J., & Bürkle, A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4503-3 · Cited by 136
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Feng, F. Y., de Bono, J. S., Rubin, M. A., & Knudsen, K. E. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.016 · Cited by 132 · cited 1×
“Nevertheless, specific PARP inhibitors have been developed for disease treatment in clinics [11,14,15,34,35].”
BackgroundNoncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice
Pétrilli, V., Herceg, Z., Hassa, P. O., Patel, N. S. A., Di Paola, R., Cortes, U., Dugo, L., Filipe, H.-M., Thiemermann, C., Hottiger, M. O., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421854 · Cited by 105
Self-citationChen, S.-H., & Yu, X. (2019) · Science Advances · doi:10.1126/sciadv.aav4340 · Cited by 105 · cited 1×
“Whilst progress has been made, these inhibitors are not efficient tools for gaining detailed information on the role of PARP1 in cellular responses to DNA insults, due in part to their side effects and interference with other pathways unrelated to PARP1 [33].”
BackgroundKashima, L., Idogawa, M., Mita, H., Shitashige, M., Yamada, T., Ogi, K., Suzuki, H., Toyota, M., Ariga, H., Sasaki, Y., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.321828 · Cited by 103 · cited 1×
“CHFR is an E3 ubiquitin ligase and known to suppress the cell cycle progression [95].”
BackgroundPoly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential
Min, W., & Wang, Z.-Q. (2009) · Frontiers in bioscience · doi:10.2741/3329 · Cited by 101
Self-citationHow Structure Defines Affinity in Protein-Protein Interactions
Erijman, A., Rosenthal, E., & Shifman, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110085 · Cited by 101 · cited 1×
“influenced by the Kd values, which vary from high (Kd ≤ 10−9 M) or medium (10−9 M < Kd ≤ 10−6 M), to low affinities (Kd > 10−6 M) [67].”
BackgroundRegulation of chromatin structure by poly(ADP-ribosyl)ation
Beneke, S. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00169 · Cited by 98
Isabelle, M., Gagné, J., Gallouzi, I., & Poirier, G. G. (2012) · Journal of Cell Science · doi:10.1242/jcs.106963 · Cited by 96 · cited 1×
“Recently, KR-rich domains, SR repeats and RG/RGG-rich domains, have been shown to bind PAR, most likely because arginine and/or lysine enrichment are positively charged and bind PAR via electrostatic forces [72,73].”
BackgroundAPLF (C2orf13) Is a Novel Component of Poly(ADP-Ribose) Signaling in Mammalian Cells
Rulten, S. L., Cortes-Ledesma, F., Guo, L., Iles, N. J., & Caldecott, K. W. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02243-07 · Cited by 95 · cited 2×
“The recruitment of APLF to DNA damage sites and tight PAR-binding via its tandem PBZ motif can contribute to the regulation of the PAR intracellular level, because overexpression of APLF reduced PAR in early stages following DNA damage [89].”
BackgroundADP-Ribosyltransferases and Poly ADP-Ribosylation
Liu, C., & Yu, X. (2015) · Current Protein and Peptide Science · doi:10.2174/1389203716666150504122435 · Cited by 94 · cited 1×
“Macrodomain MacroH2A, PARG, TARG1, MacroD1, MacroD2, macroD3, ALC1, ARTD7, ARTD8, ARTD9, PARP9, PARP14, PARP15, GDAP2 DNA damage, redox defense, chromatin architecture, protein acetylation, viral infection [79,119,120]”
Li, G.-Y., McCulloch, R. D., Fenton, A. L., Cheung, M., Meng, L., Ikura, M., & Koch, C. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000556107 · Cited by 93 · cited 1×
“Z in c fin ge r ty pe PBZ C2H2 type CX5CX6HX5H [76]”
BackgroundIdentification of potential active-site residues in the human poly(ADP-ribose) polymerase.
Simonin, F., Poch, O., Delarue, M. H., & de MURCIA, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52907-0 · Cited by 91 · cited 4×
“8% Indirect involvement in PARP activity [29]”
BackgroundInfluentialCHFR is important for the first wave of ubiquitination at DNA damage sites
Liu, C., Wu, J., Paudyal, S. C., You, Z., & Yu, X. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1278 · Cited by 91 · cited 1×
“It is recruited to damage sites by PAR and regulates the first wave of protein ubiquitination [96].”
BackgroundPolo, L. M., Xu, Y., Hornyák, P., Garcés, F., Zeng, Z., Hailstone, R., Matthews, S., Caldecott, K. W., Oliver, A. W., & Pearl, L. H. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.082 · Cited by 89
Poly-ADP ribosylation in DNA damage response and cancer therapy
Hou, W., Chen, S.-H., & Yu, X. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.09.004 · Cited by 87 · cited 2×
“For example, which of the described functions are related to the PARP1 protein itself and which are attributed to its enzymatic product PAR [2]? Several recent reviews have comprehensively described the PARP family [7,12,13] and also summarized development of PARP inhibitors in clinical applications [11,14,15].”
BackgroundPoly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer
Kwan, T. T., Bock, F. J., & Chang, P. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.03.002 · Cited by 86 · cited 1×
“WWE RNF146/Iduna, PARP11, PARP13, PARP14, Deltex1 (A and B), Deltex2 (A and B), Deltex4 (A and B), ULF, HUWE1, DDHD2 DNA damage regulation, protein degradation, mRNA stability [75,110,125,126]”
Malanga, M., Czubaty, A., Girstun, A., Staroń, K., & Althaus, F. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709495200 · Cited by 82
Rajawat, J., Shukla, N., & Mishra, D. P. (2017) · Medicinal Research Reviews · doi:10.1002/med.21442 · Cited by 77 · cited 1×
“Nevertheless, specific PARP inhibitors have been developed for disease treatment in clinics [11,14,15,34,35].”
BackgroundPoly(ADP-Ribose) Mediates the BRCA2-Dependent Early DNA Damage Response
Zhang, F., Shi, J., Bian, C., & Yu, X. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.040 · Cited by 73 · cited 5×
“Interestingly, BRCA2 depletion significantly decreases the speed of EXO1 recruitment [71], suggesting that PARylated BRCA2 facilitates EXO1 loading onto DNA breaks.”
BackgroundInfluentialMurawska, M., Hassler, M., Renkawitz-Pohl, R., Ladurner, A., & Brehm, A. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002206 · Cited by 72
Zhang, F., Chen, Y., Mo, L., & Yu, X. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318367111 · Cited by 72 · cited 2×
“OB-fold BRCA2, SSB1, SSB2, CTC1, MEIOB DNA damage [70,71]”
BackgroundThe CHD6 chromatin remodeler is an oxidative DNA damage response factor
Moore, S., Berger, N. D., Luijsterburg, M. S., Piett, C. G., Stanley, F. K. T., Schräder, C. U., Fang, S., Chan, J. A.-W., Schriemer, D. C., Nagel, Z. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08111-y · Cited by 71 · cited 1×
“Recently, KR-rich domains, SR repeats and RG/RGG-rich domains, have been shown to bind PAR, most likely because arginine and/or lysine enrichment are positively charged and bind PAR via electrostatic forces [72,73].”
BackgroundKeil, C., Gröbe, T., & Oei, S. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606470200 · Cited by 70 · cited 2×
“However, the competition for PARP1 binding between XRCC1 and PARG seems to depend on the PAR: in instances of mild DNA damage PARG removes XRCC1 from PARP1 in the damaged foci [90], while after lethal doses of alkylating agent MNNG, XRCC1 disrupts PARG-PARP1 complexes to stimulate apoptosis [92].”
BackgroundThe PIN domain of EXO1 recognizes poly(ADP-ribose) in DNA damage response
Zhang, F., Shi, J., Chen, S.-H., Bian, C., & Yu, X. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv939 · Cited by 70 · cited 4×
“EXO1 can also bind the PAR chain via the PIN domain (Kd = 200 nM) [98].”
BackgroundInfluentialChen, J.-K., Lin, W.-L., Chen, Z., & Liu, H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713912115 · Cited by 70 · cited 6×
“RRM ASF/SF2, CIRBP, FUS/TLS, TAF15, EWS, NONO DNA damage, RNA processing [85,87,99,129,130]”
BackgroundInfluentialStructure and Notch Receptor Binding of the Tandem WWE Domain of Deltex
Zweifel, M. E., Leahy, D. J., & Barrick, D. (2005) · Structure · doi:10.1016/j.str.2005.07.015 · Cited by 68
ADPriboDB: The database of ADP-ribosylated proteins
Vivelo, C. A., Wat, R., Agrawal, C., Tee, H. Y., & Leung, A. K. L. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw706 · Cited by 66
Regulating Immunity via ADP-Ribosylation: Therapeutic Implications and Beyond
Kunze, F. A., & Hottiger, M. O. (2019) · Trends in Immunology · doi:10.1016/j.it.2018.12.006 · Cited by 66 · cited 2×
“For example, which of the described functions are related to the PARP1 protein itself and which are attributed to its enzymatic product PAR [2]? Several recent reviews have comprehensively described the PARP family [7,12,13] and also summarized development of PARP inhibitors in clinical applications [11,14,15].”
BackgroundZhou, Z., Chan, C. H.-S., Xiao, Z., & Tan, E. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.6.18356 · Cited by 64 · cited 3×
“RING C3HC4 type CX2CX9-39CX1-3HX2-3CX2CX4-48CX2C [78]”
BackgroundInfluentialPARP1 deficiency exacerbates diet-induced obesity in mice
Devalaraja-Narashimha, K., & Padanilam, B. J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0402 · Cited by 63 · cited 1×
“By contrast, PARP1−/− mice in the 129/Sv background were susceptible to obesity, especially at older ages [37], and also prone to diet-induced obesity [62] (Figure 2).”
BackgroundFahrer, J., Popp, O., Malanga, M., Beneke, S., Markovitz, D. M., Ferrando‐May, E., Bürkle, A., & Kappes, F. (2010) · Biochemistry · doi:10.1021/bi1004365 · Cited by 63 · cited 2×
“H1 binds the PAR chain 10-mer and more [116].”
BackgroundStructural conservation of the PIN domain active site across all domains of life
Senissar, M., Manav, M. C., & Brodersen, D. E. (2017) · Protein Science · doi:10.1002/pro.3193 · Cited by 60 · cited 1×
“PIN-domain Compact structure β1-α1-β2-α2-β3-α3-β4-α4-β5 [81]”
Kim, I.-K., Stegeman, R. A., Brosey, C. A., & Ellenberger, T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624718 · Cited by 57 · cited 3×
“XRCC1 is recruited to DNA lesions by binding PAR chains longer than 7 units [90], required for base excision repair.”
BackgroundStructural studies of the PARP-1 BRCT domain
Loeffler, P. A., Cuneo, M. J., Mueller, G. A., DeRose, E. F., Gabel, S. A., & London, R. E. (2011) · BMC Structural Biology · doi:10.1186/1472-6807-11-37 · Cited by 55 · cited 2×
“The CAT domain contains a “PARP signature′′ sequence comprised of the NAD acceptor site and the residues contributing to the initiation, elongation, and branching of PAR [18] (Figure 1).”
BackgroundMultiple roles for poly(ADP-ribose)polymerase-1 in neurological disease
Kauppinen, T. M. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2006.11.010 · Cited by 50 · cited 1×
“Apart from being resistant to septic shock, PARP1 null mice show a certain degree of protection from other disease induction, such as ischemic stroke [55,56], traumatic brain injury [57], and streptozotocin-induced diabetes [58,59], indicating the role of PARP1 in the pathogenesis of these diseases.”
BackgroundPARPing for balance in the homeostasis of poly(ADP-ribosyl)ation
Schuhwerk, H., Atteya, R., Siniuk, K., & Wang, Z. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.09.011 · Cited by 49 · cited 4×
“Among them, PARP1 is a founding member of this family, well-known for its essential function in DNA damage repair and other cellular processes, such as chromatin remodeling, transcription and cell death signaling [2,6,7].”
BackgroundInfluentialSelf-citationRank, L., Veith, S., Gwosch, E., Demgenski, J., Ganz, M., Jongmans, M. C. J., Vogel, C., Fischbach, A., Buerger, S., Fischer, J. M. F., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw859 · Cited by 44 · cited 2×
“PARP1-E988K delayed its recruitment and persisted longer at the site of DNA lesions and induced G2 arrest in the cell cycle [63].”
BackgroundRole of poly(ADP-ribose) glycohydrolase (PARG) in shock, ischemia and reperfusion
Cuzzocrea, S., & Wang, Z. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.02.009 · Cited by 42 · cited 4×
“The lack of PARP1 leads to a remarkable decrease in the release of inflammatory mediators downstream of NF-kB transcription factor [44,54].”
BackgroundMethodInfluentialSelf-citationThe PARP1-Siah1 Axis Controls HIV-1 Transcription and Expression of Siah1 Substrates
Yu, D., Liu, R., Yang, G., & Zhou, Q. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.084 · Cited by 40
Schuhwerk, H., Bruhn, C., Siniuk, K., Min, W., Erener, S., Grigaravičius, P., Krüger, A., Ferrari, E. S., Zubel, T., Lázaro, D. R., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx717 · Cited by 36 · cited 7×
“PARP3 interacts with proteins involved in BER and NHEJ pathways, indicating its role in DNA repair.”
BackgroundInfluentialSelf-citationPARP-1 Deficiency Increases the Severity of Disease in a Mouse Model of Multiple Sclerosis
Selvaraj, V., Soundarapandian, M. M., Chechneva, O. V., Williams, A. J., Sidorov, M. K., Soulika, A. M., Pleasure, D., & Deng, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013474 · Cited by 36 · cited 1×
“In contrast, in the case of the multiple sclerosis model, they were seen to develop more severe signs of the disease [60].”
ResultSato, Y., Akitsu, M., Amano, Y., Yamashita, K., Ide, M., Shimada, K., Yamashita, A., Hirano, H., Arakawa, N., Maki, T., et al. (2013) · Journal of Cell Science · doi:10.1242/jcs.127845 · Cited by 34
Structural basis for the interaction between the cell polarity proteins Par3 and Par6
Renschler, F. A., Bruekner, S. R., Salomon, P. L., Mukherjee, A., Kullmann, L., Schütz-Stoffregen, M. C., Henzler, C., Pawson, T. J., Krahn, M. P., & Wiesner, S. (2018) · Science Signaling · doi:10.1126/scisignal.aam9899 · Cited by 33
Ying, W. (2013) · Scientifica · doi:10.1155/2013/691251 · Cited by 33
Pourfarjam, Y., Ventura, J., Kurinov, I. V., Cho, A., Moss, J., & Kim, I. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003586 · Cited by 31 · cited 1×
“Several proteins are able to bind only long chains of PAR, others bind only the branched [113] or only the linear PAR chain [114].”
BackgroundCharacterization of a Gain-of-Function Mutant of Poly(ADP-Ribose) Polymerase
Miranda, E. A., Dantzer, F., O'Farrell, M. K., de MURCIA, G., & Murcia, J. M. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1972 · Cited by 29 · cited 2×
“A gain-of-function mutation of PARP1 (L713F) was shown to have over nine times higher catalytic activity than the wild-type enzyme, but the Michaelis constant (Km) for NAD+ and the size of the PAR chain were similar to those of the intact enzyme [31].”
BackgroundPARP-1 Activation—Bringing the Pieces Together
Gagné, J., Rouleau, M., & Poirier, G. G. (2012) · Science · doi:10.1126/science.1221870 · Cited by 28 · cited 1×
“It can also be activated by events other than DNA damage, such as distorted DNA structures, interaction with proteins like histones, changes in the level of metabolites or ions, and post-translational modifications [7,19], although the biochemical mechanisms are poorly understood.”
BackgroundMansoorabadi, S. O., Wu, M., Tao, Z., Gao, P., Pingali, S. V., Guo, L., & Liu, H. (2014) · Biochemistry · doi:10.1021/bi401439n · Cited by 27 · cited 1×
“For instance, the essential role of the DNA-binding domain (DBD) is integral for activation of the protein and its enzymatic activity [20,21].”
BackgroundBranching of poly(ADP-ribose): Synthesis of the Core Motif
Kistemaker, H. A. V., Overkleeft, H. S., van der Marel, G. A., & Filippov, D. V. (2015) · Organic Letters · doi:10.1021/acs.orglett.5b02143 · Cited by 21 · cited 1×
“Once PARP1 is activated it may form a PAR chain around 200 units long, with a branching period of every 20–50 units [112].”
BackgroundBuelow, B. D., Uzunparmak, B., Paddock, M. N., & Scharenberg, A. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006339 · Cited by 18 · cited 2×
“Within this domain, three zinc fingers (ZF) are positioned at the N-terminus: ZFI (aa 1–111), ZFII (aa 117–201) and ZFIII (aa 279–333) [21].”
BackgroundLiu, Q., Kistemaker, H. A. V., Overkleeft, H. S., van der Marel, G. A., & Filippov, D. V. (2017) · Chemical Communications · doi:10.1039/c7cc05755e · Cited by 14 · cited 10×
“In addition, tandem PBZ motifs of APLF recognize branched PAR chain, while each PBZ motif can independently bind one or two ADPr residues [113].”
BackgroundInfluentialKoo, J., Yoon, H., Kim, W., Cha, D., & Choi, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030779 · Cited by 10 · cited 1×
“WWE RNF146/Iduna, PARP11, PARP13, PARP14, Deltex1 (A and B), Deltex2 (A and B), Deltex4 (A and B), ULF, HUWE1, DDHD2 DNA damage regulation, protein degradation, mRNA stability [75,110,125,126]”
Caleca, L., Colombo, M., Hansen, T. V. O., Lázaro, C., Manoukian, S., Parsons, M. T., Spurdle, A. B., & Radice, P. (2019) · Cancers · doi:10.3390/cancers11020151 · Cited by 8 · cited 1×
“BRCA2 contains three OB-folds which have been shown to bind DNA [97] and recruit exonuclease1 (EXO1) for strand resection.”
BackgroundKurokawa, S., Okuda, A., Nishizawa, Y., Furukawa, K., Sumihiro, A., Nakaji, Y., Tanaka, S., & Takehashi, M. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.025 · Cited by 4 · cited 1×
“PAR binders participate in the regulation of cell cycle progression, genome maintenance and transcription regulation [100,101].”
Background
Cited by
Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases
Thapa, K., Khan, H., Sharma, U., Grewal, A. K., & Singh, T. G. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118975 · Cited by 92
Deng, S., Vlatkovic, T., Li, M., Zhan, T., Veldwijk, M. R., & Herskind, C. (2022) · Cancers · doi:10.3390/cancers14194874 · Cited by 62
“PARP1 is the best-studied PARP enzyme and plays a key role in repairing DNA damage, as well as regulating chromatin decondensation and cell-cycle arrest [55,100].”
BackgroundDickson, K.-A., Xie, T., Evenhuis, C., Ma, Y., & Marsh, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168506 · Cited by 11
“While PARP1 is reported to conduct more than 90% of PARylation associated with DNA damage, PARPs 2, 3, 4, 5a and 5b also demonstrate PARylation activity [21,22].”
Background
Metadata
- Authors
- Kamaletdinova, T., Fanaei-Kahrani, Z., & Wang, Z.-Q.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-12-12
- Volume
- 8
- Issue
- 12
- Pages
- 1625
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2995207917
- Cited by
- 164
- References
- 130
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.